Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0000950170-25-033797

Chief Operating Officer acquired 13,987 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gault Cheryl Chief Operating Officer 2025-03-03 Grant or award +13,987 171,928 D
Loading xslF345X05/ownership.xml…